Am J Perinatol
DOI: 10.1055/a-2489-4588
Original Article

Is Pregnancy a Risk Factor for Progression of Diabetic Retinopathy and Nephropathy in Type 1 Diabetes? A Matched Cohort Study

Francis Mimouni
1   Department of Pediatrics and Research Institute, Leumit Health Services, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Jane C. Khoury
2   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
4   Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
,
Shelley Ehrlich
2   Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3   Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio
5   Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio
,
Galit Sheffer-Mimouni
6   Department of Obstetrics and Gynecology, and Research Institute, Leumit Health Services, Tel Aviv, Israel
,
Barak Rosenn
7   Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Jersey city Medical Center, Newark, New Jersey
,
Menachem Miodovnik
8   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Inova Medical Campus, Falls Church, Virginia
› Author Affiliations Funding The study was funded by the U.S. Department of Health and Human Services, National Institutes of Health (approval no.: HD 11725).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective This study aimed to test the hypothesis that the development or deterioration of nephropathy and retinopathy over time is not affected by pregnancy in women with pregestational type 1 diabetes mellitus (T1DM).

Study design Prospective, observational study of nephropathy and retinopathy follow-up during pregnancy and in a subsequent period of 2 years in a group of pregnant women with T1DM (study group) that we compared with pair-matched non-pregnant women with T1DM (control group) who underwent similar intensive follow-up.

Results The rate of renal microvascular complications was similar at entry, 17.4% (4/23) in the study group and 21.7% (5/23) in the control group. At the last visit, both groups had nephropathy rates of 17.4% (4/23) and paired p-value of 1.00. Similarly, the rate of retinal microvascular complications of any grade was similar in both groups and remained so at the last follow-up examination.

Conclusion Pregnancy per se does not appear to increase the risk for the development of, or the acceleration of the progression of retinopathy and nephropathy during a follow-up of at least 2 years in relatively healthy T1DM patients. This information is important for counseling young women with T1DM who are considering becoming pregnant.

Key Points

  • Retinopathy and nephropathy are major complications of T1DM.

  • Pregnancy per se does not appear to cause major microvascular complications in T1DM.

  • Pregnancy per se does not appear to aggravate retinopathy in T1DM.

Keywords

nephropathy - retinopathy - microvascular complications - type 1 diabetes mellitus


Publication History

Received: 30 May 2024

Accepted: 25 November 2024

Article published online:
24 December 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol 2018; 132 (06) e228-e248
    CrossrefPubMedSearch in Google Scholar
  • 2 Purdy LP, Hantsch CE, Molitch ME. et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996; 19 (10) 1067-1074
    CrossrefPubMedSearch in Google Scholar
  • 3 Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 2001; 18 (07) 573-577
    CrossrefPubMedSearch in Google Scholar
  • 4 Rosenn B, Miodovnik M, Kranias G. et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992; 166 (04) 1214-1218
    CrossrefPubMedSearch in Google Scholar
  • 5 Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP. Diabetic retinopathy in pregnancy: a population-based study of women with pregestational diabetes. J Diabetes Res 2015; 2015: 310239
    PubMedSearch in Google Scholar
  • 6 The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998; 116 (07) 874-886 Erratum in: Arch Ophthalmol 1998;116(11):1469
    CrossrefPubMedSearch in Google Scholar
  • 7 Rossing K, Jacobsen P, Hommel E. et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002; 45 (01) 36-41
    CrossrefPubMedSearch in Google Scholar
  • 8 Young EC, Pires ML, Marques LP, de Oliveira JE, Zajdenverg L. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes. Diabetes Metab Syndr 2011; 5 (03) 137-142
    CrossrefPubMedSearch in Google Scholar
  • 9 Gordon M, Landon MB, Samuels P, Hissrich S, Gabbe SG. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996; 87 (03) 401-409
    CrossrefPubMedSearch in Google Scholar
  • 10 Ballard JL, Novak KK, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979; 95 (5 Pt 1): 769-774
    CrossrefPubMedSearch in Google Scholar
  • 11 Tang SC, Chan GC, Lai KN. Recent advances in managing and understanding diabetic nephropathy. F1000 Res 2016; 5: 5
    PubMedSearch in Google Scholar
  • 12 Miodovnik M, Rosenn BM, Khoury JC, Grigsby JL, Siddiqi TA. Does pregnancy increase the risk for development and progression of diabetic nephropathy?. Am J Obstet Gynecol 1996; 174 (04) 1180-1189 , discussion 1189–1191
    CrossrefPubMedSearch in Google Scholar
  • 13 Berk MA, Miodovnik M, Mimouni F. Impact of pregnancy on complications of insulin-dependent diabetes mellitus. Am J Perinatol 1988; 5 (04) 359-367
    Thieme ConnectPubMedSearch in Google Scholar
  • 14 Nielsen LR, Ekbom P, Damm P. et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27 (05) 1200-1201
    CrossrefPubMedSearch in Google Scholar
  • 15 Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int 2001; 60 (01) 277-283
    CrossrefPubMedSearch in Google Scholar
  • 16 Andrésdóttir G, Jensen ML, Carstensen B. et al. Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int 2015; 87 (02) 417-426
    CrossrefPubMedSearch in Google Scholar
  • 17 Blodi B, Gardner TW, Gao X. et al; DCCT/EDIC Research Group. Intensive Glycemic Management Is Associated With Reduced Retinal Structure Abnormalities on Ocular Coherence Tomography in the DCCT/EDIC Study. Diabetes Care 2024; 47 (09) 1522-1529
    CrossrefPubMedSearch in Google Scholar
  • 18 Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015; 3 (11) 866-875
    CrossrefPubMedSearch in Google Scholar